pioglitazone has been researched along with Lichen Ruber Planus in 7 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone has been reported as a possible therapeutic option." | 3.11 | Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial. ( Azar, PM; Balighi, K; Daneshpazhooh, M; Dasdar, S; Ghiasi, M; Kianfar, N; Lajevardi, V; Peymanfar, AA, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 4 (57.14) | 24.3611 |
| 2020's | 2 (28.57) | 2.80 |
| Authors | Studies |
|---|---|
| Lajevardi, V | 1 |
| Ghiasi, M | 1 |
| Balighi, K | 1 |
| Daneshpazhooh, M | 1 |
| Azar, PM | 1 |
| Kianfar, N | 1 |
| Dasdar, S | 1 |
| Peymanfar, AA | 1 |
| Peterson, EL | 1 |
| Gutierrez, D | 1 |
| Brinster, NK | 1 |
| Lo Sicco, KI | 1 |
| Shapiro, J | 1 |
| Preda-Naumescu, A | 1 |
| Bevans, SL | 1 |
| Mayo, TT | 1 |
| Imanishi, H | 1 |
| Ansell, DM | 1 |
| Chéret, J | 1 |
| Harries, M | 1 |
| Bertolini, M | 1 |
| Sepp, N | 1 |
| Bíró, T | 1 |
| Poblet, E | 1 |
| Jimenez, F | 1 |
| Hardman, J | 1 |
| Panicker, SP | 1 |
| Ward, CM | 1 |
| Paus, R | 1 |
| Spring, P | 1 |
| Spanou, Z | 1 |
| de Viragh, PA | 1 |
| Mesinkovska, NA | 1 |
| Tellez, A | 1 |
| Dawes, D | 1 |
| Piliang, M | 1 |
| Bergfeld, W | 1 |
| Mirmirani, P | 1 |
| Karnik, P | 1 |
1 review available for pioglitazone and Lichen Ruber Planus
| Article | Year |
|---|---|
Pediatric Lichen Planopilaris Treated With Pioglitazone: A Case Study and Literature Review.
Topics: Alopecia; Child; Humans; Lichen Planus; Pioglitazone; Treatment Outcome | 2021 |
1 trial available for pioglitazone and Lichen Ruber Planus
| Article | Year |
|---|---|
Efficacy and safety of oral pioglitazone in the management of lichen planopilaris in comparison with clobetasol: A randomized clinical trial.
Topics: Adult; Alopecia; Clobetasol; Female; Humans; Lichen Planus; Male; Pioglitazone; Treatment Outcome | 2022 |
5 other studies available for pioglitazone and Lichen Ruber Planus
| Article | Year |
|---|---|
Response of Lichen Planopilaris to Pioglitazone Hydrochloride
Topics: Adult; Aged; Female; Humans; Immunologic Factors; Lichen Planus; Male; Middle Aged; Pioglitazone; PP | 2019 |
Epithelial-to-Mesenchymal Stem Cell Transition in a Human Organ: Lessons from Lichen Planopilaris.
Topics: Adult; Aged; Cells, Cultured; Epithelial-Mesenchymal Transition; Female; Humans; Keratin-15; Lichen | 2018 |
Lichen planopilaris treated by the peroxisome proliferator activated receptor-γ agonist pioglitazone: lack of lasting improvement or cure in the majority of patients.
Topics: Adult; Aged; Female; Humans; Lichen Planus; Male; Middle Aged; Pioglitazone; PPAR gamma; Prospective | 2013 |
The use of oral pioglitazone in the treatment of lichen planopilaris.
Topics: Administration, Oral; Alopecia; Disease Progression; Edema; Female; Follow-Up Studies; Humans; Liche | 2015 |
Lichen planopilaris treated with a peroxisome proliferator-activated receptor gamma agonist.
Topics: Alopecia; Humans; Hypoglycemic Agents; Lichen Planus; Male; Middle Aged; Pioglitazone; PPAR gamma; S | 2009 |